Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaku Nakano

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Cardiovascular Medicine|January 10, 2018
Anti-inflammatory Nanomedicine for Cardiovascular DiseaseShunsuke Katsuki, Tetsuya Matoba, Jun-Ichiro Koga, et al.
Journal of Cardiology|April 19, 2017
Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular diseaseTetsuya Matoba, Jun-Ichiro Koga, Kaku Nakano, et al.
FEBS Open Bio|October 21, 2016
Ezetimibe reduced hepatic steatosis induced by dietary oxysterols in nonhuman primatesMichiyo Deushi, Mizuko Osaka, Kaku Nakano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 11, 2012
Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemiaRyoji Nagahama, Tetsuya Matoba, Kaku Nakano, et al.
Atherosclerosis|November 28, 2006
Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeysKaku Nakano, Kensuke Egashira, Kisho Ohtani, et al.
Atherosclerosis|May 8, 2007
Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and miceKaku Nakano, Kensuke Egashira, Kisho Ohtani, et al.
International Heart Journal|July 14, 2017
Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated InflammationYajing Mao, Jun-Ichiro Koga, Masaki Tokutome, et al.
Plos One|September 8, 2016
A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine ModelKenzo Ichimura, Tetsuya Matoba, Kaku Nakano, et al.
International Heart Journal|October 30, 2018
Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in RatsKenzo Ichimura, Tetsuya Matoba, Jun-Ichiro Koga, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2004
Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primatesShiro Kitamoto, Kaku Nakano, Yasuhiko Hirouchi, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Cardiovascular Medicine|January 10, 2018
Anti-inflammatory Nanomedicine for Cardiovascular DiseaseShunsuke Katsuki, Tetsuya Matoba, Jun-Ichiro Koga, et al.
Journal of Cardiology|April 19, 2017
Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular diseaseTetsuya Matoba, Jun-Ichiro Koga, Kaku Nakano, et al.
FEBS Open Bio|October 21, 2016
Ezetimibe reduced hepatic steatosis induced by dietary oxysterols in nonhuman primatesMichiyo Deushi, Mizuko Osaka, Kaku Nakano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 11, 2012
Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemiaRyoji Nagahama, Tetsuya Matoba, Kaku Nakano, et al.
Atherosclerosis|November 28, 2006
Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeysKaku Nakano, Kensuke Egashira, Kisho Ohtani, et al.
Atherosclerosis|May 8, 2007
Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and miceKaku Nakano, Kensuke Egashira, Kisho Ohtani, et al.
International Heart Journal|July 14, 2017
Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated InflammationYajing Mao, Jun-Ichiro Koga, Masaki Tokutome, et al.
Plos One|September 8, 2016
A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine ModelKenzo Ichimura, Tetsuya Matoba, Kaku Nakano, et al.
International Heart Journal|October 30, 2018
Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in RatsKenzo Ichimura, Tetsuya Matoba, Jun-Ichiro Koga, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2004
Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primatesShiro Kitamoto, Kaku Nakano, Yasuhiko Hirouchi, et al.
Pageof 5